IGSF11 and central nervous system cancer: Furthermore, to explore the impact on survival, we examined the prognostic value of IgSF11. As demonstrated, using Kaplan-Meier curves, glioma patients with lower IgSF11 expression had prolonged survival in comparison to patients with higher expression (p = 0.0004).